MKUL · Molekule Group, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q4 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.24M | $8.35M | - | $261.3K | $70.9K | $623.2K | - | $261.3K | - | - |
| Cost of Revenue | $8.76M | $4.67M | - | $30.8K | $36.1K | $3.8K | - | $147.7K | - | - |
| Gross Profit | $4.48M | $3.68M | - | $27.6K | $34.8K | $3.0K | - | $113.6K | - | - |
| R&D | $1.17M | $243.8K | - | $633.3K | $579.1K | $1.59M | - | $813.0K | - | - |
| SG&A | $15.01M | $13.67M | - | $4.44M | $1.61M | $1.47M | - | $484.4K | - | - |
| Total Operating Expenses | $16.18M | $13.91M | - | $5.07M | $4.68M | $1.97M | - | $1.64M | - | - |
| D&A | - | $907.7K | - | $43.3K | $0 | $35.8K | - | $35.8K | - | - |
| Operating Income | ($11.70M) | ($10.23M) | - | ($5.05M) | ($2.68M) | ($1.97M) | - | - | - | - |
| Interest Expense | $1.44M | $1.25M | - | - | - | - | - | - | - | - |
| Income Tax | - | $0 | - | - | - | - | - | - | - | - |
| Net Income | - | ($9.93M) | - | $6.65M | ($2.68M) | ($1.97M) | - | ($1.53M) | - | - |
| EPS - Basic | ($0.76) | ($0.35) | - | $0.43 | ($0.37) | ($0.26) | - | ($0.36) | - | - |
| EPS - Diluted | ($0.76) | ($0.35) | - | $0.42 | ($0.24) | ($0.26) | - | ($0.36) | - | - |
Balance Sheet
| Line item | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q4 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.27M | $7.29M | $22.06M | $25.82M | $29.16M | $17.77M | $19.63M | $2.31M | $2.33M | $796 |
| Accounts Receivable | $2.21M | $1.01M | $36.2K | $11.9K | $28.1K | $6.2K | $177.1K | $201.8K | - | - |
| Inventory | $29.43M | $29.69M | $2.02M | $1.31M | $1.00M | $718.8K | $645.9K | $247.0K | - | - |
| Accounts Payable | $6.57M | $10.80M | $3.22M | $854.3K | $687.8K | $436.4K | $927.2K | $332.1K | - | - |
| Current Assets | $39.34M | $40.46M | $24.78M | $27.43M | $30.72M | $19.32M | $21.58M | $1.24M | - | - |
| Total Assets | $125.44M | $128.48M | $29.16M | $29.61M | $32.95M | $21.46M | $23.72M | $4.49M | - | - |
| Current Liabilities | $17.30M | $20.39M | $4.56M | $2.69M | $1.78M | $1.25M | $1.51M | $2.14M | - | - |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $84.73M | $64.75M | $9.46M | $5.92M | $16.70M | $1.66M | $2.01M | - | $665.3K | - |
| Stockholders' Equity | $40.71M | $63.74M | $19.70M | $23.69M | $16.25M | $21.71M | - | - | - | - |
| Retained Earnings | - | ($17.85M) | ($7.92M) | ($2.85M) | ($9.50M) | ($4.33M) | ($1.75M) | $14.41M | - | - |
Cash Flow
| Line item | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q4 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | ($16.04M) | - | - | - | ($1.72M) | - | - | - | - |
| Investing Cash Flow | - | $2.55M | - | - | - | ($1.05M) | - | - | - | - |
| Financing Cash Flow | - | ($172.0K) | - | - | - | $4.97M | - | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q4 '20 | Q4 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 33.8% | 44.0% | - | 10.5% | 49.1% | 0.5% | - | 43.5% | - | - |
| Operating margin | -88.4% | -122.6% | - | -1931.3% | -3785.4% | -316.0% | - | - | - | - |
| EBITDA margin | - | -111.7% | - | -1914.7% | -3785.4% | -310.3% | - | - | - | - |
| Net margin | - | -119.0% | - | 2544.8% | -3785.4% | -316.0% | - | -584.8% | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | 8.9% | 2.9% | - | 242.4% | 816.5% | 255.1% | - | 311.1% | - | - |
| SG&A / Revenue | 113.3% | 163.7% | - | 1699.4% | 2275.3% | 236.1% | - | 185.4% | - | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | - | -7.7% | - | 22.5% | -8.1% | -9.2% | - | -34.1% | - | - |
| Return on equity | - | -15.6% | - | 28.1% | -16.5% | -9.1% | - | - | - | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.27 | 1.98 | 5.43 | 10.20 | 17.30 | 15.49 | 14.28 | 0.58 | - | - |
| Quick ratio | 0.57 | 0.53 | 4.99 | 9.71 | 16.73 | 14.91 | 13.85 | 0.46 | - | - |
| Cash ratio | 0.30 | 0.36 | 4.84 | 9.60 | 16.42 | 14.25 | 12.99 | 1.08 | - | - |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -8.1x | -8.2x | - | - | - | - | - | - | - | - |
| Equity multiplier | 3.08 | 2.02 | 1.48 | 1.25 | 2.03 | 0.99 | - | - | - | - |
| Liabilities / Assets | 0.68 | 0.50 | 0.32 | 0.20 | 0.51 | 0.08 | 0.08 | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.11 | 0.06 | - | 0.01 | 0.00 | 0.03 | - | 0.06 | - | - |
| Inventory turnover | 0.30 | 0.16 | - | 0.02 | 0.04 | 0.01 | - | 0.60 | - | - |
| Days sales outstanding | 61d | 44d | - | 17d | 144d | 4d | - | 282d | - | - |
| Days inventory outstanding | 1226d | 2319d | - | 15510d | 10151d | 69700d | - | 610d | - | - |
| Days payable outstanding | 274d | 843d | - | 10113d | 6949d | 42315d | - | 820d | - | - |
| Cash conversion cycle | 1013d | 1520d | - | 5414d | 3347d | 27388d | - | 72d | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 18573.6% | 1239.7% | - | 0.0% | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | 12773.9% | 123684.5% | - | -75.7% | - | - | - | - | - | - |
| Operating income growth (YoY) | -335.9% | -419.6% | - | - | - | - | - | - | - | - |
| Net income growth (YoY) | - | -404.3% | - | - | - | - | - | - | - | - |
| EPS growth (YoY) | -216.7% | -34.6% | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 150.5% | 193.6% | - | - | - | - | - | - | - | - |
Peer comparison
Same SIC group: Industrial & Commercial Fans & Blowers & Air Purifing Equip
Comparing Molekule Group against the 5 most active filers in the same SIC group.